152 related articles for article (PubMed ID: 15032615)
1. Can the use of HIV-1 derived gene transfer vectors for clinical application be justified?
Fuller M; Anson DS
Curr Gene Ther; 2004 Mar; 4(1):65-77. PubMed ID: 15032615
[TBL] [Abstract][Full Text] [Related]
2. Detection of replication competent retrovirus and lentivirus.
Sastry L; Cornetta K
Methods Mol Biol; 2009; 506():243-63. PubMed ID: 19110631
[TBL] [Abstract][Full Text] [Related]
3. Lentivirus vectors using human and simian immunodeficiency virus elements.
White SM; Renda M; Nam NY; Klimatcheva E; Zhu Y; Fisk J; Halterman M; Rimel BJ; Federoff H; Pandya S; Rosenblatt JD; Planelles V
J Virol; 1999 Apr; 73(4):2832-40. PubMed ID: 10074131
[TBL] [Abstract][Full Text] [Related]
4. Development of an Rev-independent, minimal simian immunodeficiency virus-derived vector system.
Pandya S; Boris-Lawrie K; Leung NJ; Akkina R; Planelles V
Hum Gene Ther; 2001 May; 12(7):847-57. PubMed ID: 11339901
[TBL] [Abstract][Full Text] [Related]
5. Development of a novel trans-lentiviral vector that affords predictable safety.
Wu X; Wakefield JK; Liu H; Xiao H; Kralovics R; Prchal JT; Kappes JC
Mol Ther; 2000 Jul; 2(1):47-55. PubMed ID: 10899827
[TBL] [Abstract][Full Text] [Related]
6. Chimeric HIV-1 and HIV-2 lentiviral vectors with added safety insurance.
Sachdeva G; D'Costa J; Cho JE; Kachapati K; Choudhry V; Arya SK
J Med Virol; 2007 Feb; 79(2):118-26. PubMed ID: 17177309
[TBL] [Abstract][Full Text] [Related]
7. HIV-1-based lentiviral vectors.
Liu YP; Berkhout B
Methods Mol Biol; 2014; 1087():273-84. PubMed ID: 24158830
[TBL] [Abstract][Full Text] [Related]
8. Lentiviruses in gene therapy clinical research.
Connolly JB
Gene Ther; 2002 Dec; 9(24):1730-4. PubMed ID: 12457288
[TBL] [Abstract][Full Text] [Related]
9. Human immunodeficiency virus type 2 lentivirus vectors for gene transfer: expression and potential for helper virus-free packaging.
Arya SK; Zamani M; Kundra P
Hum Gene Ther; 1998 Jun; 9(9):1371-80. PubMed ID: 9650621
[TBL] [Abstract][Full Text] [Related]
10. Anti-HIV-1 gene expressing lentiviral vectors as an adjunctive therapy for HIV-1 infection.
Morris KV; Rossi JJ
Curr HIV Res; 2004 Apr; 2(2):185-91. PubMed ID: 15078182
[TBL] [Abstract][Full Text] [Related]
11. Helper plasmids for production of HIV-1-derived vectors.
Fuller M; Anson DS
Hum Gene Ther; 2001 Nov; 12(17):2081-93. PubMed ID: 11747598
[TBL] [Abstract][Full Text] [Related]
12. Requirements for efficient production and transduction of human immunodeficiency virus type 1-based vectors.
Gasmi M; Glynn J; Jin MJ; Jolly DJ; Yee JK; Chen ST
J Virol; 1999 Mar; 73(3):1828-34. PubMed ID: 9971760
[TBL] [Abstract][Full Text] [Related]
13. Safety considerations in vector development.
Kappes JC; Wu X
Somat Cell Mol Genet; 2001 Nov; 26(1-6):147-58. PubMed ID: 12465466
[TBL] [Abstract][Full Text] [Related]
14. Heterologous human immunodeficiency virus type 1 lentiviral vectors packaging a simian immunodeficiency virus-derived genome display a specific postentry transduction defect in dendritic cells.
Goujon C; Jarrosson-Wuilleme L; Bernaud J; Rigal D; Darlix JL; Cimarelli A
J Virol; 2003 Sep; 77(17):9295-304. PubMed ID: 12915545
[TBL] [Abstract][Full Text] [Related]
15. Retroviral vectors for gene therapy of AIDS and cancer.
Chang LJ; He J
Curr Opin Mol Ther; 2001 Oct; 3(5):468-75. PubMed ID: 11699891
[TBL] [Abstract][Full Text] [Related]
16. Self-inactivating lentivirus vector for safe and efficient in vivo gene delivery.
Zufferey R; Dull T; Mandel RJ; Bukovsky A; Quiroz D; Naldini L; Trono D
J Virol; 1998 Dec; 72(12):9873-80. PubMed ID: 9811723
[TBL] [Abstract][Full Text] [Related]
17. Biosafety issues in lentivector production.
Delenda C; Audit M; Danos O
Curr Top Microbiol Immunol; 2002; 261():123-41. PubMed ID: 11892244
[No Abstract] [Full Text] [Related]
18. Development of HIV vectors for anti-HIV gene therapy.
Poeschla E; Corbeau P; Wong-Staal F
Proc Natl Acad Sci U S A; 1996 Oct; 93(21):11395-9. PubMed ID: 8876146
[TBL] [Abstract][Full Text] [Related]
19. Cross-packaging of human immunodeficiency virus type 1 vector RNA by spleen necrosis virus proteins: construction of a new generation of spleen necrosis virus-derived retroviral vectors.
Parveen Z; Mukhtar M; Goodrich A; Acheampong E; Dornburg R; Pomerantz RJ
J Virol; 2004 Jun; 78(12):6480-8. PubMed ID: 15163741
[TBL] [Abstract][Full Text] [Related]
20. HIV-derived vectors for therapy and vaccination against HIV.
Di Nunzio F; Félix T; Arhel NJ; Nisole S; Charneau P; Beignon AS
Vaccine; 2012 Mar; 30(15):2499-509. PubMed ID: 22342915
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
